Trials / Completed
CompletedNCT04710771
Effect of Prone Positioning in Patients With COVID-19
Effect of Prone Positioning and Alternate Nostril Breathing Technique in Patients With COVID-19: A Quasi Experimental Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sialkott College of Physical Therapy · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
COVID-19 is affecting the people around the world and the infected individuals' may either stay asymptomatic or present to hospitals with severe distress and life threatening symptoms. The objective of the study is to investigate role of Prone positioning and alternate nostril breathing in patients with Covid-19.
Detailed description
In this quasi experimental study, 30 patients aged 40-80 years of either gender with a confirmed diagnosis of COVID-19 receiving supplemental oxygen were recruited from DHQ Hospital Faisalabad. patients were grouped into two A \& B. We collected baseline data on demographics and anthropometrics. After baseline data collection, all the patients were helped into the prone position, which was maintained for a minimum duration of three hours. After that patients in group B performed alternate nostril breathing for 10 minutes with help of physiotherapist. Clinical data were re-collected on 3rd day of intervention one hour after returning to the supine position in group A and after alternate nostril breathing in group B. The main study outcome was the variation in oxygenation (partial pressure of oxygen \[PaO2\]/ fractional concentration of oxygen in inspired air \[FiO2\]) between baseline and resupination, and General psychological state through GAD-7 General anxiety disorder questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prone Lying Position | patient lies on his/ her stomach facing floor. |
| OTHER | alternate nostril breathing | patient inspires with one nostril at a time, right or left one by one and expires by mouth. |
Timeline
- Start date
- 2020-11-23
- Primary completion
- 2021-01-15
- Completion
- 2021-01-29
- First posted
- 2021-01-15
- Last updated
- 2025-05-15
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04710771. Inclusion in this directory is not an endorsement.